what is starting dose of tirzepatide Dosage Chart: Complete Dosing Schedule and Guidelines Switching Between Semaglutide and Tirzepatide:

What they found was cost dominates treatment decisions: 68% said cost influenced their decision to start or continue treatment 44% said the medication cost more than they expected Cost surpassed side effects as the #1 reason people stopped taking GLP-1s A breakdown of the financial burden: 24% pay more than $250 per prescription fill Nearly 8% pay $500 or more per fill 24% said insurance didn't cover any cost Weight management patients were nearly twice as likely to pay $250+ vs diabetes patients --- Here's what patients are thinking: Nearly 40% ended up using discount programs or manufacturer coupons 60% know someone who wants GLP-1s but can't afford them 83% believe Americans turn to DTC programs because traditional healthcare is too expensive Patients still prioritize safety: 60% are aware of safety risks with non-FDA-approved GLP-1s--this one surprised me

2026: Acceleration and Market Transformation The coming year promises rapid evolution across innovation, policy, and market access

Tackling the root causes of chronic illness and our broken food & health system

Advances in understanding the pathogenic mechanisms of primary Sjgren syndrome (pSS) and the development of new outcome measures are aiding drug development for this disease